Regeneration and Replacement of the Corneal Endothelium: Advances in Cell Therapy, Tissue Engineering, Molecular and Pharmacologic Strategies

Study limitation reported by the research below: “The majority of novel strategies discussed (mitochondrial transfer, extracellular vesicles, ASOs, CRISPR) have no human clinical trial data yet, limiting immediate clinical applicability.”